Measuring peripheral lung dimensions with the deposition of aerosol nanoparticles Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases Year: 2021
Single-breath, real time measurement of lung deposition of tobacco smoke fine particles: the correlation between particle burden and regional particle deposition fraction Source: Annual Congress 2007 - The versatile aspects of nicotine addiction Year: 2007
Retention of ultrafine particles in the human lung Source: Eur Respir J 2004; 24: Suppl. 48, 236s Year: 2004
No evidence electric charge increases inhaled ultrafine particle deposition in human lungs Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020
Deposition of nanoparticles in the infant lung Source: Eur Respir J 2007; 30: Suppl. 51, 259s Year: 2007
Distal airspace radius estimated by nanoparticle deposition reflects lung density Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017
Inhaling nanoparticles: deposition and interaction with the respiratory tissues Source: Annual Congress 2007 - Respiratory nanomedicine: application of multifunctional nanoparticles in diagnostics and therapy Year: 2007
Deposition of ultrafine (nano)particles in the human lung and the mechanisms behing the health effects Source: International Congress 2014 – Nanomaterials and respiratory health Year: 2014
Effect of particle size of dry powder mannitol on lung deposition in healthy subjects Source: Eur Respir J 2006; 28: Suppl. 50, 434s Year: 2006
Deposition of aerosols in the lung periphery of patients with lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 212s Year: 2001
Imaging of the interaction of fine particles and nanoparticles with lung cells Source: Annual Congress 2009 - WS1 - New imaging methods for the researcher: believe what you see! Year: 2009
Negligible clearance of ultrafine particles retained in healthy and affected human lungs Source: Eur Respir J 2006; 28: 286-290 Year: 2006
Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD Source: Eur Respir J 2003; 21: 47S-51S Year: 2003
Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006
Deposition, retention and translocation of ultrafine carbonaceous particles from central and peripheral lung regions in healthy subjects and in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 459s Year: 2006
Lung-lining fluid proteins bind to ultrafine insoluble particles: a potential way for particles to pass air-blood barrier of the lung? Source: Eur Respir J 2004; 24: Suppl. 48, 100s Year: 2004
Long-term translocation kinetics of ultrafine iridium particles to and across the rat lung epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 618s Year: 2006
Does aerosol particle size predict lung dose in children? Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring Year: 2010
Bioreactivity and fate of nanoparticles deposited at the pulmonary epithelial interface: focus on traffic-derived particulate matter Source: International Congress 2016 – Traffic air pollution in urban areas Year: 2016
From air to human lungs: microanalysis of elemental deposition Source: Eur Respir J 2002; 20: Suppl. 38, 517s Year: 2002